New collaboration | A vaccine with technological concentration

 The organic combination of biotechnology and information technology will promote the development of the vaccine industry

   Vaccines are an effective means of preventing infectious diseases and have significant implications for human health. The development and use of vaccines not only play a significant role in blocking disease transmission and ensuring individual immunity, but also have a positive impact on promoting social and economic development and improving people's quality of life. In the era of digitalization, the power of technology also empowers the research and production of vaccines, enabling the full process traceability of biological vaccine production.Siemens has created a digital panoramic view of vaccine production for Minhai Biotechnology, providing computerized system verification solutions and engineering implementation services for MES, SCADA, and industrial networks, helping it achieve a digital traceability system for the entire production process.

    Through the extensive application of information technology, we have partnered with Siemens to adopt the Opcenter Exchange Pharma MES system as the core of the vaccine production information traceability system, which runs through the entire production chain from planning, production operations, equipment management, automation integration, electronic coding, inventory management, and other aspects. Through redundant and secure information networks, stable and high-speed collection, transmission, and sharing of production data can be achieved

    On the production line, SCADA has achieved automatic collection of production process data exceeding 100000 points, real-time monitoring and alarm of production line status. MES has achieved the electronic and procedural work of nearly 7000 pages of paper records for over 10 vaccine production lines, covering all main production records, dispensing records, and auxiliary records. It has verified nearly 100000 pages of documents and achieved the decomposition and issuance of production instructions, material control throughout the entire production process, electronic batch records throughout the production process, quality and batch release during the production process, and real-time data collection of key parameters during the production process. It has achieved transparency, real-time control, and traceability throughout the vaccine production process, ensuring the quality and safety of vaccines.

    In the future, Siemens will deeply cooperate with Beijing Minhai Biotechnology to continuously improve the digitalization and standardization level of the entire production process. By optimizing process standardization configuration, improving production control level, and assisting Minhai Biotechnology in completing the transformation from traditional pharmaceuticals to digitalization, we will jointly establish a high-speed industrial network that meets the digital needs of the future.